NAU professor David Wagner was recently awarded a $2.25 million grant by the U.S. Defense Threat Reduction Agency for a three-year project to better understand the life cycle and behavior of Francisella tularensis, which causes the disease tularemia. Courtesy of Northern Arizona University
Francisella tularensis is one of the most infectious pathogenic bacteria known to science-so virulent, in fact, that it is considered a serious potential bioterrorist threat. Humans can contract respiratory tularemia-a rare and deadly disease-by inhaling as few as 10 airborne organisms.
Northern Arizona University professor David Wagner, director of the Pathogen and Microbiome Institute’s (PMI) Biodefense and Disease Ecology Center, was recently awarded a $2.25 million grant by the U.S. Defense Threat Reduction Agency (DTRA) for a three-year project to better understand the life cycle and behavior of F. tularensis.
Wagner, who has been performing advanced DNA “fingerprinting” of this pathogen for almost 15 years, said that because some countries have developed biological warfare agents based on F. tularensis, it is imperative that the U.S. government develop the tools and knowledge to protect Americans from this potential threat.
“This project is critical to the science of countering weapons of mass destruction because F. tularensis is a potential biological warfare agent and its natural life cycle is poorly understood,” Wagner said.
One of the most enigmatic behaviors of the pathogen is its ability to remain dormant, in what is called a “viable but nonculturable” state-which means the bacteria is alive, but cannot be grown in the laboratory. That makes it much more difficult to study, because scientists can typically only study bacteria that can be cultured.
By performing whole-genome sequencing studies, which examine the organism’s entire genome, Wagner’s team found strains that were nearly identical genetically but separated by up to hundreds of miles and 10 years apart.
“Usually, a bacteria species will get inside a host, such as an insect or rodent, and multiply. We’d expect to see natural genetic mutations as a result,” Wagner said. “But because these strains had not mutated as we would have expected if they’d been inside a host, we theorized that the organisms were persisting in the environment in this dormant state.”
Working with co-principal investigator Jason Sahl, assistant professor and assistant director of PMI, and with long-term collaborators at the Swedish Defence Research Agency and UmeÃ¥ University, Wagner hopes to determine the environmental and genetic factors that contribute to the pathogen’s ability to remain dormant in the environment.
Although the bacteria are naturally occurring throughout the northern hemisphere, including Arizona, the number of reported cases in the United States is small, with only 230 cases in 2016, three of which occurred in Arizona. Humans can be infected through insect bites; by drinking contaminated water, which happens in developing countries such as Turkey; by handling infected animals; and by breathing aerosolized particles containing the bacteria. Humans cannot transmit the disease to other humans.
There is no vaccine to prevent tularemia, also known as rabbit fever. The disease is treated with antibiotics, and Wagner’s team is working on a related project funded by the DTRA studying the pathogen’s antibiotic resistance.
Along with their Swedish collaborators, Wagner and his team are known worldwide for their work developing the phylogeny, or global family tree, of F. tularensis and its phylogeography-mapping where different groups of the species are found throughout the world and understanding the species’ genetic diversity.
“We are excited to get this project started,” Wagner said. “We have an excellent team of scientists here at NAU and with our Swedish collaborators.”
Both undergraduate and graduate students will be working in Wagner’s lab on this project, generating data from DNA and RNA samples.
Wagner is a disease ecologist whose primary research interests are the ecology and evolution of infectious diseases. He uses genetic and genomic variation within pathogen, vector and host species to better understand the distribution, ecology, evolutionary history and transÂmission patterns of infectious diseases. Wagner, who has published more than 100 articles in scholarly journals, is one of the world’s leading experts on several pathogens and infectious diseases, including plague and tularemia. Other recent grants include two from the Centers for Disease Control and Prevention totaling $454,000 to study the prevalence of Burkholderia pseudomallei, an infectious pathogen that causes melioidosis, in Puerto Rico and the U.S. Virgin Islands.
Source: Northern Arizona University
Genomic Surveillance A New Frontier in Health Care Outbreak Detection
November 27th 2024According to new research, genomic surveillance is transforming health care-associated infection detection by identifying outbreaks earlier, enabling faster interventions, improving patient outcomes, and reducing costs.
Point-of-Care Engagement in Long-Term Care Decreasing Infections
November 26th 2024Get Well’s digital patient engagement platform decreases hospital-acquired infection rates by 31%, improves patient education, and fosters involvement in personalized care plans through real-time interaction tools.
Comprehensive Strategies in Wound Care: Insights From Madhavi Ponnapalli, MD
November 22nd 2024Madhavi Ponnapalli, MD, discusses effective wound care strategies, including debridement techniques, offloading modalities, appropriate dressing selection, compression therapy, and nutritional needs for optimal healing outcomes.
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.